MedPath

A prospective multi-national randomized comparison of the effectiveness and safety of MiniArc and Monarc.

Conditions
stress urinary incontinence
unintended urine loss.
10029903
Registration Number
NL-OMON33417
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Female symptomatic stress urinary incontinence resulting from urethral hypermobility and/or ISD (intrinsic sphincter deficiency).

Exclusion Criteria

1. Subjects who have stage 2 or more genital prolaps, according to the ICS-classification
2. Subjects who undergo surgery for recurrence of stress incontinence
3. Subjects who undergo concomitant surgical procedures
4. Subjects who are pregnant or want to become pregnant
5. Subjects are not capable of giving informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. efficacy as surgical correction of stress urinary incontinence.<br /><br>2. post-operative pain.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>3. complications.<br /><br>4. morbidity and post-operative recovery.<br /><br>5. the need for repeated stress-incontinence surgery or specialized<br /><br>physiotherapy.<br /><br>6. pelvic floor function.<br /><br>7. cost-effectiveness from a societal perspective.</p><br>
© Copyright 2025. All Rights Reserved by MedPath